Quote Dilpacimab
Dilpacimab (ABT165) is a potent dual-variable domain immunoglobulin, targets both delta-like ligand 4 (DLL4) and VEGF pathways.. Dilpacimab can be used in research of cancer.
Read more
€0.00
(tax incl.)
Reference:
HY-P99852
Brand: